SusanKSchultzMD

PubMed

• 1 citations
  Clozapine utilization at the United States Veterans Health Administration: a descriptive report of prescribing patterns and patient characteristics among Operation End...
  Zachary D. Zuschlag, Christopher A Fowler, Andrew R. Devendorf, Vanessa Panaite, Olga Efimova, Susan K. Schultz> ;International Clinical Psychopharmacology. 2020 Nov 1
• 1 citations
  Antidepressant Augmentation: A Review of the Literature and a Review of the Pharmacoeconomic Considerations.
  Glenn Catalano, Rhonda A Robeel, Grace A Cheney, Benjamin C. Spurling, Maria C. Catalano, Susan K. Schultz, Deborah L Sanchez> ;Journal of Clinical Psychopharmacology. 2020 Jul 1
• 4 citations
  Palliative Care for Dementia: 2020 Update
  Jaffrey Hashimie, Susan K. Schultz, Jonathan T. Stewart> ;Clinics in Geriatric Medicine. 2020 May 1
• Geriatric Psychiatry.
  Dan G Blazer, Susan K Schultz> ;Clinics in Geriatric Medicine. 2020 May 1
• American Association for Geriatric Psychiatry-Strategic Thinking.
  Rajesh R. Tampi, Brent P. Forester, Christopher N. Wood, Josepha A. Cheong, Christopher C. Colenda, Susan K. Schultz> ;The American Journal of Geriatric Psychiatry. 2020 Mar 1
• 5 citations
  Quality improvement in dementia care: Dementia Management Quality Measurement Set 2018 Implementation Update.
  Susan K. Schultz, Maria D. Llorente, Amy E. Sanders, Waimei A. Tai, Amy Bennett, Samantha Shugarman, Robert Roca> ;Neurology. 2020 Feb 4
• 9 citations
  Quality Improvement in Dementia Care: Dementia Management Quality Measurement Set 2018 Implementation Update
  Susan K. Schultz, Maria D. Llorente, Amy E. Sanders, Waimei A. Tai, Amy Bennett, Samantha Shugarman, Robert Roca> ;The American Journal of Psychiatry. 2020 Feb 1
• 3 citations
  Meeting Residents Halfway: the Geriatric Psychiatry Residency Track.
  Susan M. Duffy, Susan K. Schultz, Susan M. Maixner, Heba Gad, Kristina Chechotka, Nancy Williams> ;Academic Psychiatry. 2019 Feb 1
• 12 citations
  Perspectives on the Management of Vascular Depression.
  Warren D. Taylor, Susan K. Schultz, Vanessa Panaite, David C. Steffens> ;The American Journal of Psychiatry. 2018 Dec 1
• 8 citations
  Machine learning for psychiatric patient triaging: an investigation of cascading classifiers.
  Vivek K. Singh, Utkarsh Shrivastava, Lina Bouayad, Balaji Padmanabhan, Anna Ialynytchev, Susan K Schultz> ;Journal of the American Medical Informatics Association. 2018 Nov 1
• 10 citations
  Serotonin Toxicity and Urinary Analgesics: A Case Report and Systematic Literature Review of Methylene Blue-Induced Serotonin Syndrome.
  Zachary D. Zuschlag, Matthew W. Warren, Susan K. Schultz> ;Psychosomatics. 2018 Nov 1
• Geriatric Psychiatry.
  Dan G Blazer, Susan K Schultz> ;The Psychiatric Clinics of North America. 2018 Mar 1
• 5 citations
  Factors Associated With Wandering Behaviors in Veterans With Mild Dementia: A Prospective Longitudinal Community-Based Study.
  Blake Barrett, Tatjana Bulat, Susan K. Schultz, Stephen L. Luther> ;American Journal of Alzheimer's Disease and Other Dementias. 2018 Mar 1
• 7 citations
  Multi-Parametric Classification of Vascular Cognitive Impairment and Dementia: The Impact of Diverse Cerebrovascular Injury Biomarkers
  Brittany Lang, Mark S. Kindy, F. Andrew Kozel, Susan K. Schultz, Saeid Taheri> ;Journal of Alzheimer's Disease. 2018 Jan 1
• 9 citations
  2017 in Review.
  Robert Freedman, David A. Lewis, Robert Michels, Daniel S. Pine, A. John Rush, Susan K. Schultz, Carol A. Tamminga, Rachel B. Katz> ;The American Journal of Psychiatry. 2017 Dec 1
• 12 citations
  Palliative Care for Dementia.
  Jonathan T. Stewart, Susan K. Schultz> ;The Psychiatric Clinics of North America. 2017 Nov 27
• 5 citations
  Clinical repetitive transcranial magnetic stimulation for veterans with major depressive disorder.
  F. Andrew Kozel, Michael J. Hernandez, Kimberly Van Trees, Sean Phillips, Jaffrey Hashimie, Mark Weisman, Demian Obregon, Deborah L. Sanchez, Glenn Catalano, Susan K. ...> ;Annals of Clinical Psychiatry. 2017 Nov 1
• 16 citations
  Prediction of Relapse After Discontinuation of Antipsychotic Treatment in Alzheimer’s Disease: The Role of Hallucinations
  Anjali N. Patel, Seonjoo Lee, Howard Andrews, Gregory H. Pelton, Susan K. Schultz, David L. Sultzer, Jacobo Mintzer, Danilo de la Pena, Sanjay Gupta, Sylvia Colon, Cor...> ;The American Journal of Psychiatry. 2017 Apr 1
• 22 citations
  2016 in Review
  Robert Freedman, David A. Lewis, Robert Michels, Daniel S. Pine, A. John Rush, Susan K. Schultz, Carol A. Tamminga, Katherine Pier> ;The American Journal of Psychiatry. 2016 Dec 1
• 29 citations
  Autoantibodies to Collagen XVII Are Present in Parkinson's Disease and Localize to Tyrosine-Hydroxylase Positive Neurons.
  Kelly A.N. Messingham, Samantha Aust, Joseph Helfenberger, Krystal L. Parker, Susan K. Schultz, Julie McKillip, Nandakumar S. Narayanan, Janet A. Fairley> ;The Journal of Investigative Dermatology. 2016 Mar 1
• 3 citations
  2015 in Review
  Robert Freedman, David A. Lewis, Robert Michels, Daniel S. Pine, A. John Rush, Susan K. Schultz, Carol A. Tamminga, Rajiv Radhakrishnan> ;The American Journal of Psychiatry. 2015 Dec 1
• 10 citations
  Treatment of Substance Use Disorders in Older Adults: Implications for Care Delivery
  Ethan Sahker, Susan K. Schultz, Stephan Arndt> ;Journal of the American Geriatrics Society. 2015 Nov 1
• 25 citations
  Frontal hypometabolism in elderly breast cancer survivors determined by [(18)F]fluorodeoxyglucose (FDG) positron emission tomography (PET): a pilot study.
  Laura L. Boles Ponto, Yusuf Menda, Vincent A. Magnotta, Torricia H. Yamada, Natalie L. Denburg, Susan K. Schultz> ;International Journal of Geriatric Psychiatry. 2015 Jun 1
• 9 citations
  2014 in review
  Robert Freedman, David A. Lewis, Robert Michels, Daniel S. Pine, Susan K. Schultz, Carol A. Tamminga, Misty Richards> ;The American Journal of Psychiatry. 2014 Dec 1
• 10 citations
  2013 in review
  Robert Freedman, David A. Lewis, Robert Michels, Daniel S. Pine, Susan K. Schultz, Carol A. Tamminga, Arshya Vahabzadeh> ;The American Journal of Psychiatry. 2013 Dec 1
• Join now to see all

Journal Articles

• Predictive structural dynamic network analysis  
  Chen R, et al ADNI, J Neurosci Methods, 1/30/2015
• Gaussian Mixture Models and Model Selection for [18F] Fluorodeoxyglucose Positron Emission Tomography Classification in Alzheimer's Disease  
  Li R, et al ADNI, PLoS One, 1/28/2015
• Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE  
  Ayton S, et al ADNI, Nat Commun, 1/19/2015
• Memory, executive, and multidomain subtle cognitive impairment: Clinical and biomarker findings  
  Toledo JB et al, ADNI, Neurology, 1/17/2015
• Brain structure and function as mediators of the effects of amyloid on memory  
  Mattsson N, et al ADNI, Neurology, 1/17/2015
• Common genetic variants influence human subcortical brain structures  
  Hibar DP, et al, ADNI, Nature, 1/9/2015
• The future is now: model-based clinical trial design for Alzheimer's disease  
  Romero K, et al; ADNI, Clin Pharmacol Ther, 1/1/2015
• Improved longitudinal [(18)F]-AV45 amyloid PET by white matter reference  
  Brendel M, et al ADNI, Neuroimage, 1/1/2015
• Effects of changing from non-accelerated to accelerated MRI for follow-up in brain atrophy measurement  
  Leung KK, et al ADNI, Neuroimage, 1/1/2015
• The mediational effects of FDG hypometabolism on the association between cerebrospinal fluid biomarkers and neurocognitive function  
  Dowling NM, et al ADNI, Neuroimage, 1/1/2015
• Studying ventricular abnormalities in mild cognitive impairment with hyperbolic Ricci flow and tensor-based morphometry  
  Shi J, et al, ADNI, Neuroimage, 1/1/2015
• Epidemic spreading model to characterize misfolded proteins propagation  
  Iturria-Medina Y, et al; ADNI, PLoS Comput Biol, 1/20/2014
• Subjective cognitive complaints contribute to misdiagnosis of mild cognitive impairment  
  Edmonds EC, et al; ADNI, J Int Neuropsychol Soc, 1/1/2014
• Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals  
  Paterson RW, et al ADNI, Transl Psychiatry, 1/1/2014
• Altered effective connectivity patterns of the default mode network in Alzheimer's disease: an fMRI study  
  Zhong Y, et al; ADNI, Neurosci Lett, 1/1/2014
• Overrepresentation of glutamate signaling in Alzheimer's disease: network-based pathway enrichment using meta-analysis of genome-wide association studies  
  Pérez-Palma E, et al ADNI; NIA-LOAD/NCRAD Family Study Group, PLoS One, 1/1/2014
• Automatic ROI selection in structural brain MRI using SOM 3D projection  
  Ortiz A, et al, ADNI, PLoS One, 1/1/2014
• Testing for association with multiple traits in generalized estimation equations, with application to neuroimaging data  
  Zhang Y, et al ADNI, Neuroimage, 1/1/2014
•  
  Mattsson N, et al; ADNI, PLoS One, 1/31/2013
• Mapping the genetic variation of regional brain volumes as explained by all common SNPs from the ADNI study  
  Bryant C, et al ADNI, PLoS One, 1/1/2013
• Improved inference in Bayesian segmentation using Monte Carlo sampling: application to hippocampal subfield volumetry  
  Iglesias JE, et al ADNI, Med Image Anal, 1/1/2013
• CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology  
  Bradshaw EM, et al ADNI, Nat Neurosci, 1/1/2013
• Functional activity maps based on significance measures and Independent Component Analysis  
  Martínez-Murcia FJ, et al ADNI, Comput Methods Programs Biomed, 1/1/2013
• Brain changes in older adults at very low risk for Alzheimer's disease  
  Fjell AM, et al ADNI, J Neurosci, 1/1/2013
• aBEAT: a toolbox for consistent analysis of longitudinal adult brain MRI  
  Dai Y, et al; ADNI, PLoS One, 1/1/2013
• Join now to see all

Books/Book Chapters

• Substance Use and Older People 
  Chapter: Epidemiology and Demography of Alcohol and the Older Person 
  Arndt S, Schultz SKEditors: IB Crome, L-T Wu, RT Rao, P Crome.New York: Wiley2014
• Neurobiology of Mental Illness 
  Chapter: DSM-5 Overview and Goals in Neurobiology of Mental Illness 
  Kupfer DJ, Schultz SKEditors: Charney DS, Buxbaum JD, Skar P, Nestler.Oxford, England2014
• Diagnostic and Statistical Manual of Mental Disorders 
  Schultz SKAmerican Psychiatric Association, Arlington, VAEdition 5th,2013
• The Conceptual Evolution of DSM-5 
  Chapter: Part V: Diagnostic Issues Relating to Lifespan from Adulthood into Later Life 
  Faison WE, Schultz SKEditors: Regier DA, Narrow WE, Kuhl E, Kupfer DJ.American Psychiatric Publishing2011
• Psychiatric Diagnosis: A Research Agenda for DSM-V 
  Chapter: Part III: The Elderly. Aging-related diagnostic variations: Age and Gender Considerations 
  Schultz SK, Alexopoulos GSEditors: Narrow WE, First MB, Sirovatka PJ, Regier, DS.American Psychiatric Publishing2007
• Geriatric Review Syllabus 
  Schultz SKAmerican Geriatrics Society and Kendall Hunt publishingEdition 6th,2006
• Aging and Schizophrenia 
  Chapter: Biological changes with aging and schizophrenia 
  Schultz SKEditors: Cohen C.American Psychiatric Press2003
• Positive and negative symptoms in schizophrenia 
  Fuller R, Schultz SK, Andreasen NEditors: Hirsh.Blackwell Publishing2002
• This Side of Doctoring: Reflections from Women in Medicine 
  Chapter: On reaching visible 
  Schultz SKEditors: Chin EL.Sage Publications, London2002
• Geriatric Medicine 
  Chapter: Psychotic Disorders in The Geriatric Review Syllabus, A Core Curriculum 
  Schultz SKEditors: Cobbs EL and Duthie EH.American Geriatric SocietyEdition 5th,2000
• Current Issues in the Psychopharmacology of Schizophrenia 
  Chapter: The neuroanatomy of schizophrenia 
  Schultz SK, Nopoulos PC, Andreasen NCEditors: Breier A, Tran PV, Herrera J, Bymaster F.Williams and Wilkens, Baltimore, MD2000
• The Neuropathology of Schizophrenia 
  Chapter: Integrating functional and structural imaging 
  Andreasen NC and Schultz SKOxford University Press, Oxford, England1999
• The Geriatric Review Syllabus, A Core Curriculum in Geriatric Medicine 
  Chapter: Contributing question and critique author for Psychotic Disorders 
  Schultz SKEditors: Cobbs EL and Duthie EH.American Geriatric SocietyEdition 4th,1998
• Psychiatric Treatment of the Medically Ill 
  Chapter: Effects of aging on psychotropic efficacy and toxicity 
  Schultz SK and Miller DDEditors: Robinson RG and Yates WR.Marcell Decker, Inc, New York, NY1998
• The Textbook of Women's Health 
  Chapter: Brain and Behavior 
  Nopoulos PC, Schultz SK, Andreasen NCEditors: Wallis LA.Little, Brown and Co, Boston, MA1997
• Geriatric Psychopharmacology 
  Chapter: Treatment of poststroke depression 
  Robinson RG, Schultz SK, Paradiso SEditors: Nelson JC.Marcell Decker, Inc, New York, NY1997
• Focus on Depression 
  Chapter: Clinical correlates of early-onset and late-onset poststroke generalized anxiety 
  Castillo CS, Schultz SK, Robinson RGEditors: Vermeulen E.PMSI, Almere-Stad, The Netherlands1996
• Proceedings from Symposium: The Economics of Schizophrenia 
  Chapter: Assessing the symptoms of schizophrenia in Handbook of Mental Health Economics and Health Policy 
  Andreasen NC, Schultz SKEditors: Moscarelli M, Rupp A, Sartorius N.Milan, Italy1993
• Join now to see all

Abstracts/Posters

• Brain pH and Alzheimer’s pathology
  Ponto, LLB, Schultz SK, Jacob M, Menda Y, Magnotta VA, Society for Nuclear Medicine and Molecular Imaging, Annual Meeting, 1/1/2014
• Decisional aides to train non-psychiatrists in evidence based use of antipsychotics in dementia
  Weckmann M, Daly J, Gryzlak B, Kelly M, Lenoch S, Levy B, Reist J, Schultz SK, Seydel L, Smith M, Carnahan R, Academy of Psychosomatic Medicine Annual Meeting; College of Psychiatric and Neurologic Pharmacists Annual Meeting; American Health Care Association/National Center for Assisted Living Quality Symposium, Phoenix, AZ, 2011; Tampa, FL, 2012; Houston, TX, 2012, 1/24/2012
• Development of a reader-friendly patient and family guide to facilitate shared decision making on antipsychotic use in dementia
  Carnahan R, Abrams MA, Weckmann M, Savage B, Daly J, Kelly M, Levy B, Mulhausen P, Reist J, Seydel L, Smith M, Raether R, Abrams E, Holland R, Schultz SK, Health Literacy Iowa and New Readers of Iowa Conference, Des Moines, IA, 1/14/2012
• Structural MRI Correlates of Neurocognitive Performance in Breast Cancer Survivors
  Hamsakutty H, Yamada TH, Denburg N, Magnotta V, Beglinger L, Nopoulos P, Schultz SK, American Association for Geriatric Psychiatry, San Antonio, TX, 1/12/2011
• The Antipsychotic Discontinuation in Alzheimer's Disease (ADAD) trial: clinical rationale and study design
  Devanand DP, Mintzer J, Schultz SK, Sultzer D, de la Pena D, Gupta S, Colon S, Schimming, C, Pelton, G, Andrews H, Levin B, International Congress on Alzheimer's Disease, 1/1/2011
• Dementia, goals of care, and surrogate decision making toward the end of life
  Kaldjian LC, Shinkunas LA, Bern-Klug ME, Schultz SK, Society of General Internal Medicine 32nd Annual Meeting, Miami Beach, FL, 1/14/2009
• Neuropsychological Outcomes of Long-term Breast Cancer Survivors
  Yamada T, Denburg N, Beglinger L, Schultz SK, AAGP, Honlulu, HI, 1/7/2009
• [18F]Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) Study of Brain Metabolism among Elderly Breast Cancer Survivors
  Schultz SK, Menda Y, Denburg N, Ponto LB, Am. College of Neuropsychopharmacology, Hollywood, FL, 1/7/2009
• Mild Cognitive Impairment assessed by [15O]water Positron Emission Tomography: Differences in Cerebral Blood Flow among Cognitive Subtypes
  Duff K, Ponto LLB, Moser D, Schultz SK et al, American College of Neuropsychopharmacology, San Juan, Puerto Rico, 1/13/2004
• Cerebrovascular reserve capacity in mild cognitive impairment assessed by [15O] water positron emission tomography
  Schultz SK, Ponto LLB, Magnotta V, et al, American College of Neuropsychopharmacology, San Juan, Puerto Rico, 1/11/2003
• Assessment of cerebrovascular reserve capacity among persons with mild cognitive impairment using [15O] water positron emission tomography
  Schultz SK, Ponto LLB, Magnotta V, et al, American College of Neuropsychopharmacology, San Juan, Puerto Rico, 1/14/2002
• Associations between cognitive impairment and depressive symptoms in late-life: gender effects
  Filips J, Bayless J, Moser DJ, Crossett J, Schultz SK, First Annual International Congress for Geriatric Psychoneuropharmacology, Kona, HI, 1/15/2001
• Psychiatric syndromes in the nursing home patient: longitudinal follow-up study
  Schultz SK, Ellingrod VL, Ekstam-Smith K, et al, American College of Neuropsychopharmacology Annual Meeting, Kona, HI, 1/12/2001
• Clinical characteristics of late-life psychosis: a comparison of diagnostic groups
  Schultz SK, Ellingrod VL, Moser DJ, et al, American Journal of Geriatric Psychiatry, 1/1/2001
• The relationship between neuroleptic-induced akathisia and depressive symptoms
  Atbasoglu C, Schultz SK, Andreasen NC, APA Annual Meeting, 1/1/2000
• Effects of psychiatric symptoms on functional skills among long-term care patients
  Schultz SK, Ellingrod V, Moser D, Arndt S, NCDUE annual meeting, Boca Raton, FL, 1/1/2000
• Age and gender effects on the expression of depressive symptoms in schizophrenia
  Schultz SK, Ho BC, Andreasen NC, American College of Neuropsychopharmacology Annual Meeting, 1/1/2000
• Association between cytochrome P4502D6 (CYP2D6) genotype, neuroleptic exposure, and abnormal involuntary movements
  Ellingrod VL, Schultz SK, Arndt S, International Congress for Schizophrenia Research Annual meeting, 1/1/1999
• A retrospective analysis of the hypoglycemic treatment of schizophrenia
  Schultz SK and Dornink R, Am J Geriatr Psychiatry, 1/1/1998
• A positron emission tomography study of age-related changes in regional cerebral blood flow
  Schultz SK, O’Leary DS, Andreasen NC, Society for Neuroscience 28th Annual Meeting, 1/1/1998
• Heart rate variability before and after electroconvulsive therapy in patients with major depressive disorder
  Schultz SK, Van de Borne P, Anderson E, Proceedings of the American Association for Geriatric Psychiatry annual meeting, 1/1/1997
• Sympathetic activity and metabolic rate in patients with anorexia nervosa
  Schultz SK, Van de Borne P, Anderson E, American Psychiatric Association Annual Meeting, 1/1/1997
• Effects of low versus high potency neuroleptic withdrawal on symptoms and dyskinetic movements
  Schultz SK, Miller DD, Arndt S, Andreasen NC, Schiz Research, 1/1/1997
• Clinical variables associated with suicide in patients with schizophrenia
  Ziebell S, Schultz SK, Andreasen NC, Schizophrenia Research, 1/1/1997
• Schizophrenia and aging: a comparison of symptoms among age groups
  Schultz SK, Oliver S, Arndt S, Miller D, Andreasen NC, Am J Geriatr Psychiatry, 1/1/1996
• Join now to see all

Lectures

• APA Council on Aging 
  1/18/2015
• Advances in Geriatric Psychiatry 
  Toronto, ON - 1/17/2015
• Non-AD Dementias and Delirium 
  1/1/2015
• New Tests to Help Diagnose Alzheimer’s Disease 
  Lone Tree, IA - 1/28/2014
• Understanding the Diagnosis and Progression of Memory Decline and Dementia 
  1/28/2014
• Breakthroughs in Science, Beneficence in Care 
  Orlando, FL - 1/17/2014
• Healthcare in the Elderly 
  Iowa City, IA - 1/25/2013
• Diagnostic Imaging in Alzheimer’s and Other Dementias 
  Iowa City, IA - 1/25/2013
• New Advances in Alzheimer’s Research 
  1/12/2012
• Brain Imaging and New Diagnostic Measures for Alzheimer’s Disease 
  Iowa City, IA - 1/3/2012
• Managing Dementia Patients with Behavioral Disturbances 
  Des Moines, IA - 1/2/2012
• Managing Behavioral Symptoms of Dementia 
  Chicago, IL - 1/17/2011
• Risk Factors for Mild Cognitive Impairmen 
  Chicago, IL - 1/16/2011
• Emotional and Behavioral Problems with Aging 
  Waterloo, IA - 1/16/2011
• New Research on the Diagnosis and Treatment of Alzheimer’s Disease 
  1/16/2011
• Psychiatric Issues for Older Adults 
  Iowa City, IA - 1/7/2011
• Potential Cognitive Effects of Chemotherapy among Long-term Cancer Survivors 
  Pittsburgh, PA - 1/26/2010
• Understanding Neuropsychological Outcomes among Women Breast Cancer Survivors 
  Minneapolis, MN - 1/17/2010
• Diagnosis of Dementia 
  1/10/2010
• Cancer and Aging: Breast Cancer Survivors and Cognitive Outcomes 
  Savannah, GA - 1/7/2010
• Management of Emotional Problems in Dementia 
  1/1/2010
• Elderly Women Breast Cancer Survivors: Cognitive Outcomes 
  1/15/2009
• Emerging Immunotherapies for Alzheimer’s Disease 
  1/13/2009
• Mechanisms and Emerging Treatments for Alzheimer’s Disease 
  1/12/2009
• Emotional Changes in Late life: Issues for Caregivers 
  1/12/2009
• Join now to see all

Other

• Memory Problems 
  Schultz SK, American Geriatrics Society's Foundation for Health in Aging (FHA)
  http://www.healthinaging.org/public_education/eldercare/17.xml
  1/1/2003
• Dementia Teaching Module 
  Schultz SK, Iowa Geriatric Education Center (IGEC)
  1/1/2000